|
JPS59196876A
(ja)
|
1983-04-22 |
1984-11-08 |
Sumitomo Chem Co Ltd |
１，２，４−オキサジアゾ−ル誘導体、その製造法およびそれを有効成分とする除草剤
|
|
WO1986003203A1
(en)
*
|
1984-11-22 |
1986-06-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylthiazole derivatives
|
|
CA2044533A1
(en)
*
|
1990-06-29 |
1991-12-30 |
Philippe Guerry |
Substituted aminoalkylbiphenyl derivatives
|
|
WO1995032963A1
(fr)
*
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienylazole et compose de thienotriazolodiazepine
|
|
WO1996004278A1
(fr)
|
1994-08-02 |
1996-02-15 |
Nippon Soda Co., Ltd. |
Derive d'oxazole, son procede de production et herbicide
|
|
AU3264695A
(en)
*
|
1994-08-23 |
1996-03-14 |
Nissan Chemical Industries Ltd. |
Pyridine derivative
|
|
DE19536809A1
(de)
|
1995-10-02 |
1997-04-03 |
Basf Ag |
Heterocyclisch substituierte Salicylsäurederivate
|
|
CA2190699A1
(en)
*
|
1995-12-08 |
1997-06-09 |
Johannes Aebi |
Tertiary amines
|
|
JP2000505052A
(ja)
*
|
1996-01-05 |
2000-04-25 |
ノバルティス アクチェンゲゼルシャフト |
除草剤として役立つ置換化１，２，４，６―チアトリアジン
|
|
US6268308B1
(en)
|
1996-08-27 |
2001-07-31 |
Syngenta Crop Protection, Inc. |
Herbicidal S-substituted 1,2,4,6-thiatriazines
|
|
JPH11171848A
(ja)
*
|
1997-09-26 |
1999-06-29 |
Fujirebio Inc |
芳香族アミド誘導体
|
|
UA71971C2
(en)
*
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
US6586453B2
(en)
*
|
2000-04-03 |
2003-07-01 |
3-Dimensional Pharmaceuticals, Inc. |
Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1
|
|
US20030171399A1
(en)
*
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
EP1356276A4
(en)
|
2000-12-26 |
2005-02-02 |
Res Dev Foundation |
ACETYL-COENZYME A CARBOXYLASE 2 AS A TARGET IN THE REGULATION OF BULK FAT, FAT STORAGE, ENERGY HOMEOSTASY AND INSULIN ACTION
|
|
ES2275887T3
(es)
|
2001-06-07 |
2007-06-16 |
Eli Lilly And Company |
Moduladores de receptores activados por proliferadores de peroxisoma (ppar).
|
|
US6987123B2
(en)
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
|
ES2407807T3
(es)
*
|
2001-08-13 |
2013-06-14 |
Janssen Pharmaceutica N.V. |
Derivados de tiazolilo 2-amino-4,5-trisustituidos y su uso frente a enfermedades autoinmunitarias
|
|
WO2003026661A1
(fr)
*
|
2001-09-14 |
2003-04-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine
|
|
JP2005162612A
(ja)
*
|
2002-01-09 |
2005-06-23 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
WO2003072100A1
(en)
|
2002-02-25 |
2003-09-04 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
EP1478437B1
(en)
*
|
2002-02-27 |
2005-08-31 |
Pfizer Products Inc. |
Acc inhibitors
|
|
BR0316193A
(pt)
*
|
2002-12-12 |
2005-09-27 |
Galderma Res & Dev |
Composto, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
|
|
TW200500362A
(en)
*
|
2003-04-09 |
2005-01-01 |
Japan Tobacco Inc |
5-membered heteroaromatic ring compound and pharmaceutical use thereof
|
|
JP2005272476A
(ja)
*
|
2003-04-09 |
2005-10-06 |
Japan Tobacco Inc |
複素芳香５員環化合物及びその医薬用途
|
|
WO2004106307A2
(fr)
|
2003-05-27 |
2004-12-09 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament
|
|
AU2004249430B2
(en)
|
2003-06-20 |
2011-08-18 |
Galderma Research & Development, S.N.C. |
Novel compounds that modulate PPARgamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
|
GB2404855A
(en)
|
2003-07-07 |
2005-02-16 |
Pantherix Ltd |
Arylcarboxylic acid derivatives and their therapeutic use
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
BRPI0412347A
(pt)
*
|
2003-07-30 |
2006-09-05 |
Cyclacel Ltd |
2-aminofenil-4-fenilpiridinas como inibidores de quinase
|
|
AU2004268112A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Merck & Co., Inc. |
Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
|
|
EP1677791A4
(en)
|
2003-10-31 |
2007-08-15 |
Takeda Pharmaceutical |
NITROGENIC CONDENSED HETEROCYCLIC COMPOUNDS
|
|
EP1687299A1
(en)
|
2003-11-20 |
2006-08-09 |
Eli Lilly And Company |
Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treamtment and/or prevention of disorders modulated by a ppar
|
|
EP1694670A1
(en)
*
|
2003-12-16 |
2006-08-30 |
GPC Biotech AG |
Pyrazine derivatives as effective compounds against infectious diseases
|
|
BRPI0418148A
(pt)
*
|
2003-12-25 |
2007-04-17 |
Takeda Pharmaceutical |
composto, prodroga de um composto, modulador da função do receptor gpr40, agente farmacêutico, uso de um composto e métodos de modificação de uma função do receptor gpr40 em um mamìfero, de profilaxia ou tratamento de diabetes em um mamìfero e de produção de um composto
|
|
US7470712B2
(en)
|
2004-01-21 |
2008-12-30 |
Bristol-Myers Squibb Company |
Amino-benzazoles as P2Y1 receptor inhibitors
|
|
US20050267221A1
(en)
|
2004-05-14 |
2005-12-01 |
Research Development Foundation |
Use of curcumin and analogues thereof as inhibitors of ACC2
|
|
EP1893572B1
(en)
|
2004-06-18 |
2016-12-14 |
Millennium Pharmaceuticals, Inc. |
Factor xa inhibitors
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
JP2006022065A
(ja)
|
2004-07-09 |
2006-01-26 |
Dai Ichi Seiyaku Co Ltd |
カルバメート誘導体
|
|
EP1786792B1
(en)
*
|
2004-07-27 |
2009-04-08 |
Astellas Pharma Inc. |
Thiazole derivatives having vap-1 inhibitory activity
|
|
EP1789393A2
(en)
*
|
2004-07-30 |
2007-05-30 |
GPC Biotech AG |
Pyridinylamines
|
|
MX2007008434A
(es)
*
|
2005-01-19 |
2007-07-25 |
Squibb Bristol Myers Co |
Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos.
|
|
EP1996567B1
(en)
*
|
2006-02-15 |
2013-09-18 |
AbbVie Inc. |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
US8748627B2
(en)
*
|
2006-02-15 |
2014-06-10 |
Abbvie Inc. |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
WO2008079610A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Abbott Laboratories |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
EP2581081A3
(en)
*
|
2007-06-01 |
2013-07-31 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
